On behalf of its Partner (the Contracting Authority), the Education Procurement Service (EPS) invites responses (“Tenders”) to this Request for Tenders (“RFT”) from economic operators (“Tenderers”) for the supply of the Goods as described in Appendix 1 to this RFT,
University College Dublin (UCD) is a dynamic, modern University and is the largest University in Ireland with seven Colleges and thirty-eight Schools offering a comprehensive range of undergraduate and postgraduate programmes in the humanities and the sciences. Its student population is almost 24,000, including 1,400 international students. Approximately 25% of the student body is engaged in postgraduate study and research. UCD is committed to maintaining a high level of research activity and to further developing its collaborative links with industry and commerce, and with educational and research institutions internationally. UCD is also a major employer with over 4,000 permanent personnel (full-time and part-time) and 3,000 fee paid personnel. For further information on UCD please visit www.ucd.ie
About the UCD Genomic Project
Next generation sequencing (NGS) has hugely impacted on research, and now will step change clinical diagnostics. Many diseases have a genetic contribution and some, such as cancer, are caused by genetic mutations. By NGS we can exactly determine the genetic composition, structural variation and mutations of each individual patient allowing an exact molecular and personalised diagnosis that is necessary and will pave the way for personalised treatments. UCD seeks to set up such a NGS infrastructure for personalised health diagnostics that will cater for both research based NGS studies as well as clinical diagnostics. The Conway is in an ideal position because of the close connection to University Hospitals and the Ireland East Hospital Group (IEHG), and in particular the availability of the substantial bioinformatics expertise that is an absolute necessity for large scale and high quality NGS studies. This expertise is critically enhanced by UCD’s Systems Biology Ireland Centre (SBI) which offers an unrivalled capability to interpret genomic changes with a view of developing personalised therapies. Establishing such a NGS sequencing capability will add value to (i) the research capacity of UCD in the life sciences and biomedicine; and (ii) provide the IEHG the first state of the art NGS facility for diagnostic and clinical research applications.
General Requirements:
|
Lots |
Equipment Type |
|
1 |
High throughput sequencing platform consisting of High throughput desktop sequencer; Automated sequencing library preparation station; and cloud based LIMS and analysis solution |
|
2 |
High performance compute (HPC) cluster for data storage and analysis. |
|
3 |
Sonicator for the fragmentation of DNA/RNA for the production of sequencing libraries |